Clinical Trials
67 trialsNGS as the First-line Treatment in Advanced Biliary Tract Cancer
National Health Research Institutes, Taiwan
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
InnoPharmax Inc.
Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric Adenocarcinoma
Yonsei University
Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.
Takara Bio Inc.
DIGEST
Taiho Oncology, Inc.
KEYNOTE-659
Merck Sharp & Dohme LLC
LOTS
National Cheng-Kung University Hospital
SOHUG
Kangbuk Samsung Hospital
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
University of California, San Francisco
ARTIST-II
Samsung Medical Center
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
ChineseAMS
Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer
Yonsei University
Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer
National Taiwan University Hospital
S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Hallym University Medical Center
Docetaxel and S-1 for Advanced Esophageal Cancer
Hallym University Medical Center
Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer
Hallym University Medical Center
Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer
Fujian Cancer Hospital
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
The First People's Hospital of Changzhou
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
3G
National University Hospital, Singapore
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer
ChineseAMS
GC-A-003
ChineseAMS
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Hokuriku-Kinki Immunochemotherapy Study Group
Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes
Peking Union Medical College Hospital
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Hallym University Medical Center
SOPP
Asan Medical Center
Sorafenib Plus S-1 in Advanced Solid Tumors
National Health Research Institutes, Taiwan
Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
Japan Breast Cancer Research Network
A Phaseâ…¡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
Peking University
A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer
Yonsei University
The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer
ChineseAMS
Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Gemcitabine and S-1 for Advanced Biliary Tract Cancer
Hallym University Medical Center
TORCH
Seoul National University Hospital
A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer
Yonsei University
Postoperative Chemoradiotherapy With S-1 in Gastric Cancer
Chonnam National University Hospital
Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer
ChineseAMS
Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer
ChineseAMS
Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.
GEST
Taiho Pharmaceutical Co., Ltd.
Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer
Hallym University Medical Center
Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
Hallym University Medical Center
TPSHNSCC
Chonnam National University Hospital
Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer
Xijing Hospital
TMOG-GC01
Tokyo Metropolitan Oncology Group
S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)
Second Military Medical University
Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma
Samsung Medical Center